Availability and Pharmacoeconomics of Insulin Therapy in Countries with the Largest Number of Diabetics
The aim of the review was to analyze the availability of insulin therapy and the ways to improve it in countries with the largest number of patients with diabetes. It was also aimed to assess the medical, social and economic importance of insulin therapy and industrial production of therapeutic reco...
Main Author: | S. V. Ponomarenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2019-10-01
|
Series: | Фармакоэкономика |
Subjects: | |
Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/299 |
Similar Items
-
Pharmacoeconomic comparison of insulin glargine and insulin detemir in diabetes mellitus type 2
by: I. N. Dyakov, et al.
Published: (2020-05-01) -
Pharmacoeconomic simulation of delayed results of the treatment of type 2 diabetes mellitus with modern insulin analogsin comparison with oral hypoglycemic agents
by: Ivan Ivanovich Dedov, et al.
Published: (2010-03-01) -
Cost Excursion Study of Various Insulin Preparations Available in India
by: Mayur B Phulpagare, et al.
Published: (2021-07-01) -
Pharmacoeconomic analysis of clinical efficiency of combined metformin (Siofor) - insulin therapy in patients with type 2 diabetes mellitus
by: I Yu Demidova, et al.
Published: (2009-06-01) -
Basal insulin analogues in the diabetes mellitus type 2 control — economic aspects
by: D. Yu. Belousov, et al.
Published: (2018-06-01)